ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Carrier-free nanoassembly of doxorubicin prodrug and siRNA for combinationally inducing immunogenic cell death and reversing immunosuppression

Chen, Senbiao; Li, Dongdong; Du, Xiaojiao*; He, Xinyu; Huang, Mengwen; Wang, Yang; Yang, Xianzhu*; Wang, Jun*1
Nano Today2020-12DOI: 10.1016/j.nantod.2020.100924
72被引7阅读
引用收藏
分享

摘要

Doxorubicin (DOX) can elicit antitumor immunity responses by inducing immunogenic cell death (ICD) but also triggers upregulated expression of various immunosuppressive genes to counteract the ICD effect. To resolve this conflict, a carrier-free nanoassembly of acid-activatable DOX prodrug and small interfering RNA (siRNA) was developed to combinationally induce ICD and reverse immunosuppression. The carrier-free nanoassembly with rather high drug contents (4.13 % for siRNA and 21.67 % for DOX) was formed via cooperative pi-pi stacking and electrostatic interactions. The formed nanoassembly, termed as PEG@D:siRNA, possessed a well-defined nanostructure: a core consisting of DOX plus siRNA and a shell consisting of polyethylene glycol (PEG). It has been demonstrated that this carrier-free nanoassembly carrying siRNA targeting PD-L1 can significantly increase tumor-infiltrating T lymphocytes, improve interferon-gamma (IFN-gamma) expression, and ultimately strengthen the ICD effect of the DOX prodrug, resulting in a significantly enhanced anticancer immune response and superior tumor growth inhibition. In addition, carrier-free nanoassembly PEG@D:siRNA can also be conveniently extended as a general strategy to combine chemotherapy and immunotherapy, providing a facile avenue for improving cancer chemoimmunotherapy.

学科与关键词

关键词
Carrier-free delivery systemImmunogenic cell deathPD-L1 knockdownReversion of immunosuppressionCombination therapy
相关
加载中…
  • Nanoassembly of doxorubicin-conjugated polyphosphoester and siRNA simultaneously elicited macrophage- and T cell- mediated anticancer immune response for cancer therapy
    Li, Dongdong; Cao, Ziyang; Chen, Chaoran; Li, Hengyi; He, Shan; Hou, Xurui; Liang, Ming*; Yang, Xianzhu*; Wang, Jun*Biomaterials, 2023, 302: 122339.被引 3
  • Designing Peptide-Based Nanoinhibitors of Programmed Cell Death Ligand 1 (PD-L1) for Enhanced Chemo-immunotherapy
    Xie, Fengjuan; Tang, Shasha; Zhang, Ye; Zhao, Yinbing; Lin, Yingying; Yao, Yining; Wang, Meiyan*; Gu, Zhengying*; Wan, Jingjing*ACS Nano, 2024, 18(2): 1690-1701.
  • Self-delivery oxidative stress amplifier for chemotherapy sensitized immunotherapy
    Zhao, Linping; Zheng, Rongrong; Liu, Lingshan; Chen, Xiayun; Runtian, Guan; Yang, Ni; Chen, Ali; Yu, Xiyong*; Cheng, Hong*; Li, Shiying*Biomaterials, 2021, 275: 120970.被引 49
查看全部 →

发表信息

论文状态
公开发表
期刊
Nano Today
发表日期
2020-12
卷期
第 35 卷
页码
100924
DOI
10.1016/j.nantod.2020.100924
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
1区
成果收录
SCIE
资助标注
National Key R&D Program of China [2017YFA0205600]; National Natural Science Foundation of China [51633008, 51773067, 51822302, 31870996]; Program for Guangdong Introducing innovative and Enterpreneurial Teams [2017ZT07S054]; High-level Hospital Construction Project [DFJH201905]; Natural Science Foundation for Distinguished Young Scholars of Guangdong Province [2017B030306002]; Guangdong Provincial Pearl River Talents Program [2017GC010713, 2017GC010482]; Outstanding Scholar Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110102001]; Fundamental Research Funds for the Central Universities

作者

  • C

    Chen, Senbiao (第一作者)

    1

  • L

    Li, Dongdong

    1

查看全部 8 位作者收起作者
  • D

    Du, Xiaojiao (通讯)

    1

  • H

    He, Xinyu

    1

  • H

    Huang, Mengwen

    1

  • W

    Wang, Yang

    1

  • Y

    Yang, Xianzhu (通讯)

    1

  • W

    Wang, Jun (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417